INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 230
Summary
- Conditions
- Bladder Cancer
- Castration Resistant Prostate Cancer
- Non -Small Cell Lung Cancer
- Ovarian Cancer
- Squamous Cell Carcinoma of Head and Neck
- Triple -Negative Breast Cancer
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Masking Description: Open LabelPrimary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04580485
- Collaborators
- Not Provided
- Investigators
- Study Director: Sven Gogov, M.D Incyte Corporation
Get Well Soon